Added on Aug 04, 2009. Average rating: 4.00/5.00 (n=1)
Submitting regulatory documents electronically to the FDA is beneficial for sponsors and regulatory reviewers, but the use of electronic submissions brings with it a set of problems associated with how these documents are read by reviewers.
Submitting regulatory documents electronically to the FDA is beneficial for sponsors and regulatory reviewers, but the use of electronic submissions brings with it a set of problems associated with how these documents are read by reviewers.